Document is current

Any future updates will be listed below

Correction to: Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts

Crossref DOI link: https://doi.org/10.1186/s12967-021-02916-0

Published Online: 2021-06-21

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark